Human Optogenetic Vision Study Reaches Peer Review

Company GenSight Biologics; Institute of Molecular and Clinical Ophthalmology Basel (IOB) Event Type Peer-reviewed clinical study Modality Optogenetic AAV gene therapy with light-stimulating goggles Asset GS030 (AAV2.7m8-ChrimsonR-tdTomato) Target Retinal ganglion cells (ChrimsonR opsin expression) Disease Area Advanced retinitis pigmentosa Summary A peer-reviewed early clinical study…